المؤلفون: Daniel Bradshaw, Iga Abramowicz, Stephen Bremner, Sumita Verma, Yvonne Gilleece, Sarah Kirk, Mark Nelson, Rosalie Housman, Helena Miras, Chloe Orkin, Ashini Fox, Michael Curnock, Louise Jennings, Mark Gompels, Emily Clarke, Rachel Robinson, Pauline Lambert, David Chadwick, Nicky Perry

مصطلحات موضوعية: Gastroenterology and hepatology, Infectious diseases, Metabolic medicine, Maraviroc use, fibrosis, Hepatological biomarkers, fatty liver non alcoholic, Non-invasive assessment of liver fibrosis, Randomised Control Trial (RCT), HIV-1, pilot trial, feasibility trial

Relation: https://figshare.com/articles/dataset/Dataset_for_Hepmarc_a_96_week_randomised_controlled_feasibility_trial_of_add-on_maraviroc_in_people_with_HIV_and_non-alcoholic_fatty_liver_disease/22815686

الاتاحة: https://doi.org/10.25377/sussex.22815686.v1
https://figshare.com/articles/dataset/Dataset_for_Hepmarc_a_96_week_randomised_controlled_feasibility_trial_of_add-on_maraviroc_in_people_with_HIV_and_non-alcoholic_fatty_liver_disease/22815686